|
|
Title | Creator | Description | Identifier |
1 |
|
Optical Coherence Tomography Angiography Findings in Pre-Clinical, Biomarker Positive Alzheimer's Disease | Bliss Elizabeth O'Bryhim; Nathan Kung; Rajendra Apte; Gregory Van Stavern | Alzheimer's disease (AD) is marked by slowly progressive memory loss, behavioral changes, and deterioration of executive function. Approved treatments prevent further neurodegeneration, but symptoms of AD only become apparent after irreversible loss has already occurred. Optical coherence tomography... | 20180306_nanos_sciplatform2_06 |
2 |
|
Optical Coherence Tomography Angiography Findings in Pre-Clinical, Biomarker Positive Alzheimer's Disease | Bliss Elizabeth O'Bryhim; Nathan Kung; Rajendra Apte; Gregory Van Stavern | Alzheimer's disease (AD) is marked by slowly progressive memory loss, behavioral changes, and deterioration of executive function. Approved treatments prevent further neurodegeneration, but symptoms of AD only become apparent after irreversible loss has already occurred. Optical coherence tomography... | 20180306_nanos_sciplatform2_06-2 |
3 |
|
Optical Coherence Tomography Angiography Findings in Pre-Clinical, Biomarker Positive Alzheimer's Disease | Bliss Elizabeth O'Bryhim; Nathan Kung; Rajendra Apte; Gregory Van Stavern | Alzheimer's disease (AD) is marked by slowly progressive memory loss, behavioral changes, and deterioration of executive function. Approved treatments prevent further neurodegeneration, but symptoms of AD only become apparent after irreversible loss has already occurred. Optical coherence tomography... | 20180306_nanos_sciplatform2_06-1 |